Celularity, Inc

Warren,  NJ 
United States
  • Booth: 836

Celularity is a clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies, engineered from the postpartum human placenta, in cancer immunotherapy and functional regeneration. Some of our placenta-derived allogeneic cell therapy products aim to augment immunity by harnessing a patient’s own immune system to combat disease. Our other products seek to augment longevity by targeting organ and tissue repair and functional regeneration. 

Brands: BIOVANCE® - Human Amniotic Membrane Allograft and Interfyl® - human connective tissue matrix derived from the chorionic plate of the placenta